iCare for Cancer Patients
Stopped early · Not applicable
Conditions studied: Myelodysplastic Syndromes, Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Acute Lymphoid Leukemia, Leukemia, Acute Lymphoblastic, Multiple Myeloma, Myelofibrosis
In brief
The purpose of this study is to use genomic information from individual patients to create simulation avatars that will be used to predict novel drug combinations with therapeutic potential.
Key facts
- Study ID
- NCT02435550
- Run by
- University of Florida
- People needed
- 136
- Starts
- 2015-06-26
- Expected to finish
- 2019-10-01
- Last updated by the study team
- 2019-12-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Individuals known or suspected of having a blood cancer or hematologic disorder
- Individuals with presence of extramedullary disease
- Capable of providing informed consent.
You may not qualify if…
- Does not have a blood cancer or a hematologic disorder
Where it is running
- UF Health Shands Cancer Hospital — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.